Simulations Plus, Inc. Logo

Simulations Plus, Inc.

Modeling & simulation software and consulting for pharma/biotech to accelerate drug development.

SLP | NDAQ

Overview

Corporate Details

ISIN(s):
US8292141053
LEI:
Country:
United States of America
Address:
800 PARK OFFICES DRIVE, SUITE 401, 27709 RESEARCH TRIANGLE PARK
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Simulations Plus, Inc. is a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and other science-based industries. The company specializes in solutions that support drug discovery and development, from early research and clinical development to regulatory submissions. Its flagship products, including GastroPlus® and ADMET Predictor®, utilize advanced technologies like AI/machine learning, physiologically based pharmacokinetic (PBPK), quantitative systems pharmacology (QSP), and quantitative systems toxicology (QST) modeling. These tools enable scientists to predict the properties and effects of chemical and biological compounds, helping to optimize drug design, predict safety and efficacy, and accelerate the development timeline. The company serves a global client base, including major pharmaceutical companies, regulatory agencies, and academic institutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Simulations Plus, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Simulations Plus, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Simulations Plus, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.
South Korea 095700
GENFLOW BIOSCIENCES PLC Logo
Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.
United Kingdom GENF
GENINUS Inc. Logo
AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.
South Korea 389030
genOway Logo
Develops custom genetically modified preclinical models for biopharma and academic research.
France ALGEN
Genpact LTD Logo
Drives business transformation for enterprises using AI, data, and technology services.
United States of America G
GenSight Biologics S.A. Logo
Developing gene therapies for neurodegenerative diseases of the eye and central nervous system.
France SIGHT
GeoVax Labs, Inc. Logo
Developing vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
United States of America GOVX
GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. Logo
A travel agency offering online booking for transport, hotels, cultural tours, and cruises.
Türkiye GZNMI
GIG Works Inc. Logo
Connects businesses with gig workers, offering staffing, BPO, IT, and coworking services in Japan.
Japan 2375
An investment company providing global marketing and promotion services, focusing on UK businesses.
Cayman Islands GCAP

Talk to a Data Expert

Have a question? We'll get back to you promptly.